课题基金 / 基金详情

Phase 1 COVID-19 Immunity - National Core Study

Phase 1 COVID-19 Immunity - National Core Study
COVID-19 免疫第一阶段 - 国家核心研究
批准号:
MC_PC_20060
负责人:
Paul Moss
金额:
$999.65万
依托单位:
依托单位国家:
英国
项目类别:
Intramural
财政年份:
2021
资助国家:
英国
项目状态:
已结题
起止时间:
2021 至 --

项目摘要

项目成果

Paul Moss的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
The magnitude and quality of a person's immune response remains a central determinant of clinical outcome following SARS-CoV-2 infection and vaccines now provide an approach for pandemic control. The NCSi programme is designed to co-ordinate and build on UK investments in understanding COVID-19 immunity. These are based around four themes which seek to predict and manage individual risk, protect against acute infection and late effects of infection, prevent primary infection or re-infection, and prepare for future pandemic challenges.
期刊论文(10)
专著(0)
科研奖励(0)
会议论文
DOI: 10.1016/s2468-1253(22)00005-x
发表时间: 2022-04
期刊: The lancet. Gastroenterology & hepatology
影响因子: --
作者: [Alexander JL, Kennedy NA, Ibraheim H, Anandabaskaran S, Saifuddin A, Castro Seoane R, Liu Z, Nice R, Bewshea C, D'Mello A, Constable L, Jones GR, Balarajah S, Fiorentino F, Sebastian S, Irving PM, Hicks LC, Williams HRT, Kent AJ, Linger R, Parkes M, Kok K, Patel KV, Teare JP, Altmann DM, Boyton RJ, Goodhand JR, Hart AL, Lees CW, Ahmad T, Powell N, VIP study investigators]
通讯作者: VIP study investigators
DOI: 10.1111/imm.13450
发表时间: 2022-05
期刊: Immunology
影响因子: 6.4
作者: []
通讯作者:
DOI: 10.1016/j.lanepe.2023.100816
发表时间: 2024-02
期刊: LANCET REGIONAL HEALTH-EUROPE
影响因子: 20.9
作者: [Bedston, Stuart, Almaghrabi, Fatima, Patterson, Lynsey, Agrawal, Utkarsh, Woolford, Lana, Anand, Sneha N, Joy, Mark, Crawford, Anna, Goudie, Rosalind, Byford, Rachel, Abbasizanjani, Hoda, Smith, Deb, Laidlaw, Lynn, Akbari, Ashley, Sullivan, Christopher, Bradley, Declan T, Lyons, Ronan A, de Lusignan, Simon, Hobbs, F D Richard, Robertson, Chris, Sheikh, Sir Aziz, Shi, Ting]
通讯作者: Shi, Ting
DOI: 10.1016/s2468-1253(22)00274-6
发表时间: 2022-11
期刊: LANCET GASTROENTEROLOGY & HEPATOLOGY
影响因子: 35.7
作者: [Alexander, James L., Liu, Zhigang, Sandoval, Diana Munoz, Reynolds, Catherine, Ibraheim, Hajir, Anandabaskaran, Sulak, Saifuddin, Aamir, Seoane, Rocio Castro, Anand, Nikhil, Nice, Rachel, Bewshea, Claire, D'Mello, Andrea, Constable, Laura, Jones, Gareth R., Balarajah, Sharmili, Fiorentino, Francesca, Sebastian, Shaji, Irving, Peter M., Hicks, Lucy C., Williams, Horace R. T., Kent, Alexandra J., Linger, Rachel, Parkes, Miles, Kok, Klaartje, Patel, Kamal V., Teare, Julian P., Altmann, Daniel M., Goodhand, James R., Hart, Ailsa L., Lees, Charlie W., Boyton, Rosemary J., Kennedy, Nicholas A., Ahmad, Tariq, Powell, Nick]
通讯作者: Powell, Nick
8
    COVID-19 Immunity - National Core Study (IMM-NCS)
    • 批准号:
      MC_PC_20031
    • 项目类别:
      Intramural
    • 资助金额:
      $917.42万
    • 财政年份:
      2020
    • 负责人:
      Paul Moss
    • 依托单位:
    A UK underpinning platform to study immunology and immunopathology of COVID-19:The UK Coronavirus Immunology Consortium
    • 批准号:
      MR/V028448/1
    • 项目类别:
      Research Grant
    • 资助金额:
      $838.0万
    • 财政年份:
      2020
    • 负责人:
      Paul Moss
    • 依托单位:
    University of Birmingham - Proximity to Discovery 2017
    • 批准号:
      MC_PC_17183
    • 项目类别:
      Intramural
    • 资助金额:
      $25.7万
    • 财政年份:
      2018
    • 负责人:
      Paul Moss
    • 依托单位:
    The T cell immune response to cytomegalovirus across the adult lifecourse
    • 批准号:
      MR/R011230/1
    • 项目类别:
      Research Grant
    • 资助金额:
      $235.61万
    • 财政年份:
      2018
    • 负责人:
      Paul Moss
    • 依托单位:
    国内基金
    海外基金
    CEACAM5调控Galectin-9介导的CD4+T细胞极化在COVID-19肠屏障损伤的作用机制研究
    • 批准号:
      82370569
    • 项目类别:
      面上项目
    • 资助金额:
      49万元
    • 批准年份:
      2023
    • 负责人:
      李啸峰
    • 依托单位:
    COVID-19疫情对我国儿童生长发育影响的异质性研究
    • 批准号:
      42371429
    • 项目类别:
      面上项目
    • 资助金额:
      52.00万元
    • 批准年份:
      2023
    • 负责人:
      张知新
    • 依托单位:
    传染病模型的稳态切换过程研究及其在治疗COVID-19中的应用
    • 批准号:
      LQ23A010016
    • 项目类别:
      省市级项目
    • 资助金额:
      --
    • 批准年份:
      2023
    • 负责人:
      罗敏
    • 依托单位:
    “湿漫膜原”视角下研究加味达原饮重塑COVID-19“免疫炎症稳态”的分子机制:TLR4介导IRF3/NF-κB通路串扰
    • 批准号:
      82374291
    • 项目类别:
      面上项目
    • 资助金额:
      48万元
    • 批准年份:
      2023
    • 负责人:
      张传涛
    • 依托单位: